Last reviewed · How we verify
NCT06282380: FDA-AF
Fibricheck Detection cApabilities for Atrial Fibrillation
NA trial testing FibriCheck Mobile Application in Atrial Fibrillation in 330 participants. Completed in 26 June 2024.
26 June 2024
Quick facts
| Lead sponsor | Qompium NV |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 330 |
| Start date | 26 February 2024 |
| Primary completion | 26 June 2024 |
| Estimated completion | 26 June 2024 |
| Sites | 5 locations across Belgium, United States |
Drugs / interventions tested
- FibriCheck Mobile Application
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Qompium NV
Who can join
22 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of accuracy of the FibriCheck Mobile Application on various smartphone devices, compared to the reference diagnosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06282380
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Qompium NV trials
Trials by the same sponsor.
- NCT06422468 — Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring · NA · recruiting
- NCT04374344 — Qualitative Analysis of Photoplethysmography Waveforms for the Detection of Cardiac Arrhythmias · completed
- NCT03620656 — The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation · completed
- NCT03509493 — Detection of Atrial Fibrillation in Different Patient Target Groups Using the FibriCheck Smartphone Application · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06282380 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qompium NV
- Last refreshed: 27 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06282380.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing